| 2871 |
Formulation and Evaluation of Famotidine Sublingual Tablets.
|
Department of Pharmaceutics |
2005 |
| 2872 |
Formulation and Evaluation of Famotidine Sublingual Tablets.
|
Department of Pharmaceutics |
2005 |
| 2873 |
Formulation and Evaluation of Famotidine Sublingual Tablets.
|
Department of Pharmaceutics |
2005 |
| 2874 |
Hepatic effects of novel selenazolidine prodrugs of selenocysteine developed as potential cancer chemopreventive agents. |
Department of Medicinal Chemistry |
2005 |
| 2875 |
Improvement of absorption enhancing effects of n-dodecyl-β-D- maltopyranoside by its colon-specific deliver using chitosan capsules. |
Department of Pharmaceutics |
2005 |
| 2876 |
Improvement of absorption enhancing effects of n-dodecyl-β-D- maltopyranoside by its colon-specific deliver using chitosan capsules. |
Department of Pharmaceutics |
2005 |
| 2877 |
Improvement of absorption enhancing effects of n-dodecyl-β-D- maltopyranoside by its colon-specific deliver using chitosan capsules. |
Department of Pharmaceutics |
2005 |
| 2878 |
Nitric oxide donors can enhance the intestinal transport and absorption of insulin and [Asu1,7]-eel calcitonin in rats. |
Department of Pharmaceutics |
2005 |
| 2879 |
Nitric oxide donors can enhance the intestinal transport and absorption of insulin and [Asu1,7]-eel calcitonin in rats. |
Department of Pharmaceutics |
2005 |
| 2880 |
Nitric oxide donors can enhance the intestinal transport and absorption of insulin and [Asu1,7]-eel calcitonin in rats. |
Department of Pharmaceutics |
2005 |